China Pharma Holdings Inc (CPHI) — Capital Reinvestment Ratio
China Pharma Holdings Inc (CPHI) has a Capital Reinvestment Ratio of 0.03x as of June 2025, meaning it reinvests 0% of its operating cash flow ($291.08K) in capital expenditures ($9.92K). Check CPHI goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China Pharma Holdings Inc Capital Reinvestment Ratio (2007–2019)
This chart tracks China Pharma Holdings Inc's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see China Pharma Holdings Inc (CPHI) cash flow conversion.
Annual Capital Reinvestment Ratio for China Pharma Holdings Inc (2007–2019)
Year-by-year Capital Reinvestment Ratio for China Pharma Holdings Inc from 2007 to 2019. See free cash flow generation of China Pharma Holdings Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.22x | $608.31K | $136.00K | ▲ +449.5% |
| 2018 | 0.04x | $1.26 Million | $51.15K | ▼ -74.9% |
| 2017 | 0.16x | $841.22K | $136.48K | ▲ +142.9% |
| 2016 | 0.07x | $2.90 Million | $193.40K | ▼ -90.4% |
| 2015 | 0.69x | $3.35 Million | $2.32 Million | ▼ -45.8% |
| 2014 | 1.28x | $4.57 Million | $5.84 Million | ▼ -42.5% |
| 2013 | 2.22x | $8.60 Million | $19.09 Million | ▲ +62.3% |
| 2012 | 1.37x | $3.64 Million | $4.99 Million | ▲ +29.3% |
| 2011 | 1.06x | $5.24 Million | $5.54 Million | ▼ -21.7% |
| 2010 | 1.35x | $7.79 Million | $10.52 Million | ▼ -6.2% |
| 2009 | 1.44x | $10.67 Million | $15.36 Million | ▲ +10.9% |
| 2008 | 1.30x | $6.54 Million | $8.49 Million | ▲ +21.7% |
| 2007 | 1.07x | $2.80 Million | $2.99 Million | — |